Although these findings highlight the potential for FTO to be a therapeutic target in cancer treatment, recent studies have indeed demonstrated that FTO promotes LUAD progression, for example by regulating autophagy,11 the miR‐181b‐3p/ARL5B axis,12 or the stability of USP7 mRNA.13 The gene discussed is FTO; the disease is cancer.